Andrea Remuzzi and Giuseppe Remuzzi

Review: Potential protective effects of telmisartan on renal function deterioration
J Renin Angiotensin Aldosterone Syst 2006 7: 185-191. [Abstract] [PDF] [References]  

Natalia de las Heras, Marta Ruiz-Ortega, Mónica Rupérez, David Sanz-Rosa, María Miana, Paloma Aragoncillo, Sergio Mezzano, Vicente Lahera, Jesús Egido, and Victoria Cachofeiro

Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II
J Renin Angiotensin Aldosterone Syst 2006 7: 192-200. [Abstract] [PDF] [References]  

Walmor C De Mello

Chronic blockade of angiotensin II AT1-receptors increased cell-to-cell communication, reduced fibrosis and improved impulse propagation in the failing heart
J Renin Angiotensin Aldosterone Syst 2006 7: 201-205. [Abstract] [PDF] [References]  

Salah Kassab, Taysir Garadah, Marwan Abu-Hijleh, Jamal Golbahar, Solomon Senok, Javed Wazir, and Khalid Gumaa

The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats
J Renin Angiotensin Aldosterone Syst 2006 7: 206-211. [Abstract] [PDF] [References]  

Bogdan Gurzu, Bogdan Cristian Petrescu, Marcel Costuleanu, and Gheorghe Petrescu

Interactions between apelin and angiotensin II on rat portal vein
J Renin Angiotensin Aldosterone Syst 2006 7: 212-216. [Abstract] [PDF] [References]  

Willemijn AKM Windt, Atsua Tahara, Alex CA Kluppel, Dick de Zeeuw, Robert H Henning, and Richard PE van Dokkum

Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy
J Renin Angiotensin Aldosterone Syst 2006 7: 217-224. [Abstract] [PDF] [References]  

Wenxia Chai, Yvonne M Hoedemaekers, Ron HN van Schaik, Marianne van Fessem, Ingrid M Garrelds, Jasper J Saris, Dennis Dooijes, Folkert J ten Cate, Marcel MJ Kofflard, and AH Jan Danser

Cardiac aldosterone in subjects with hypertrophic cardiomyopathy
J Renin Angiotensin Aldosterone Syst 2006 7: 225-230. [Abstract] [PDF] [References]  

Julie Sanders, Joanna Harris, Jackie Cooper, Peter Gohlke, Steve E Humphries, Hugh Montgomery, and David R Woods

Lack of change in serum angiotensin-converting enzyme activity during the menstrual cycle
J Renin Angiotensin Aldosterone Syst 2006 7: 231-235. [Abstract] [PDF] [References]  

Vivencio Barrios, Carlos Escobar, Alberto Calderon, Juan Pablo Tomás, Soledad Ruiz, Jose Luis Moya, Alicia Megias, Onofre Vegazo, and Raul Fernandez

Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice The VIPE study
J Renin Angiotensin Aldosterone Syst 2006 7: 236-242. [Abstract] [PDF] [References]  

Roberto Negro and Haslinda Hassan

The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients
J Renin Angiotensin Aldosterone Syst 2006 7: 243-246. [Abstract] [PDF] [References]  

Domenic A Sica

The pharmacology of agents that interfere with renin-angiotensin system activity
J Renin Angiotensin Aldosterone Syst 2006 7: 247-250. [PDF] [References]  

Atsuhiro Ichihara

Resolving the mysteries of the renin-angiotensin system in diabetes
J Renin Angiotensin Aldosterone Syst 2006 7: 250-251. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.